Standex International (SXI) Earnings Date & Reports

Key Takeaways

• Standex International (SXI) is scheduled to report fiscal fourth quarter 2026 results on Thursday, July 30, after the market closes, with a conference call to follow on Friday, July 31, at 8:30 a.m. ET.
• Wall Street consensus estimates point to adjusted earnings per share (EPS) of approximately $2.35, which would represent a modest increase from the $2.28 reported in the same quarter last year.
• Revenue expectations center around $226.5 million, compared with $222.0 million in Q4 fiscal 2025, reflecting continued organic growth across the company's Electronics and Aerospace & Defense segments.
• Company guidance calls for slightly to moderately higher sequential revenue and adjusted operating margin, though year-over-year margin comparisons may face headwinds from growth investments and higher costs.
• The report follows a rare Q3 miss, where adjusted EPS of $2.21 came in a penny below consensus — raising the stakes for a return to Standex's historical beat streak.
• Fast-growth end markets — including the electrical grid, commercialization of space, and defense — remain central to the investment narrative and will be closely scrutinized for momentum heading into fiscal 2027.

Earnings Context and Why It Matters

Standex International's Q4 fiscal 2026 report marks the close of a transformative year for the Salem, New Hampshire-based diversified manufacturer. Over the past twelve months, the company has continued executing a deliberate portfolio shift toward higher-growth, higher-margin engineered solutions — rebranding its Engineering Technologies segment as Standex Aerospace & Defense, divesting the Federal Industries business to sharpen focus, and reducing net leverage to approximately 1.9x. With the stock trading at elevated levels and the company targeting $1.1 billion in revenue and 23% operating income by fiscal 2028, this earnings release serves as both a report card on fiscal 2026 execution and a signal for the trajectory ahead. Investors will be watching for confirmation that organic growth momentum, new product contributions, and fast-growth market expansion remain firmly on track.

Earnings Expectations

Analyst consensus for the fiscal fourth quarter ended June 30, 2026, projects adjusted EPS of $2.35, according to data aggregated by TipRanks and Finviz, with estimates ranging from $2.25 to $2.57 across five covering analysts. On the top line, consensus revenue sits at approximately $226.5 million, compared with $222.0 million in Q4 fiscal 2025, implying year-over-year growth of roughly 2%.

During its Q3 earnings call in late April, management provided specific forward commentary: sequential revenue is expected to be slightly to moderately higher, supported by mid-to-high-single-digit organic growth, stronger backlog in fast-growth markets, and increased new-product sales. Adjusted operating margin is also forecast to improve sequentially but face slight year-over-year compression, as growth investments, elevated medical costs, and increased variable compensation offset productivity gains. The company also guided for Q4 interest expense of $6.8 million to $7.0 million and full-year capital expenditures of $27 million to $30 million.

Key metrics beyond the headline numbers include the Electronics segment book-to-bill ratio — which stood at a robust 1.14 in Q3 — new product sales growth (up roughly 40% in Q3), and the contribution from fast-growth end markets, which management expects to reach approximately $270 million, or roughly 30% of total fiscal 2026 sales. Standex has historically exceeded consensus EPS estimates in six of its last eight quarters, making the narrow Q3 miss a notable exception that adds weight to this upcoming report.

AI Screener

Identifying earnings-season opportunities across thousands of stocks can be time-consuming for both retail and professional investors. Tickeron's AI Screener addresses this challenge by offering an AI-powered stock and ETF discovery platform that filters the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of securities using customizable criteria such as industry classification, market capitalization, technical indicators, price patterns, and performance metrics. Whether looking for breakout candidates, trending stocks ahead of earnings, or under-the-radar names aligned with specific strategies, the AI Screener is designed to surface relevant trade ideas more efficiently than traditional manual screening. Explore the screener to see how AI can sharpen your market research workflow.

Market Reaction and Investor Sentiment

Standex shares have delivered a strong run over the past year, touching an all-time high of $363.89 in late June 2026, driven by enthusiasm around the company's exposure to secular growth themes in grid infrastructure, aerospace, and defense. However, the stock pulled back following the Q3 FY2026 report in April, when both EPS and revenue narrowly missed consensus — a rare stumble for a company that had beaten estimates in five consecutive quarters prior. Sentiment heading into the Q4 release appears cautiously constructive. Analyst ratings remain unanimously positive, with a consensus Strong Buy and a mean price target near $291, though that target sits below recent trading levels, reflecting valuation sensitivity. The implied earnings move, as measured by the options market, will be a key signal of how much uncertainty is priced into the event. Given the company's consistent execution track record and the strategic progress made during fiscal 2026, the market is likely to reward a clean beat-and-raise scenario while punishing any sign of slowing momentum in core growth verticals.

Forward Outlook and Key Factors to Monitor

Looking beyond the Q4 print, several themes will shape the Standex investment narrative as fiscal 2027 begins. The company's long-term targets — $1.1 billion in revenue and 23% operating margin by fiscal 2028 — represent a significant step-up from current levels and will require sustained execution across multiple fronts.

New product introductions remain a cornerstone of the organic growth strategy. Standex launched 16 new products in fiscal 2025 and has committed to more than 15 additional releases in fiscal 2026, with each cohort expected to contribute approximately 300 basis points (bps) of incremental growth. Investors should monitor both the cadence of launches and the revenue ramp from recently introduced products. A basis point equals one-hundredth of a percentage point.

Fast-growth end markets — spanning the electrical grid, electric and hybrid vehicles, renewable energy, commercialization of space, and defense — are projected to account for roughly 30% of total company sales in fiscal 2026, up from approximately 28% in fiscal 2025. Sustained order momentum in these verticals, particularly within the rebranded Aerospace & Defense segment and the Amran/Narayan Grid business, will be critical for maintaining above-market growth rates.

Margin trajectory deserves close attention. While adjusted operating margin reached a record 20.6% in Q4 fiscal 2025, the company has signaled that near-term investments in capacity expansion, talent, and new product development may create modest margin headwinds before yielding returns. The balance between investing for growth and delivering near-term profitability will be a recurring theme on the earnings call.

Capital allocation is another factor to track. The Federal Industries divestiture generated roughly $62 million in debt paydown proceeds, lowering net leverage to approximately 1.9x. With a healthy balance sheet and an active merger and acquisition (M&A) pipeline, Standex has ample capacity to pursue bolt-on acquisitions that complement its engineered components portfolio — particularly in aerospace, defense, and grid-related niches.

Finally, the broader macroeconomic environment — including global trade policy, tariff developments, and industrial demand trends — will continue to influence sentiment. Standex's regional manufacturing footprint provides some insulation, but any deterioration in key end markets could weigh on the company's organic growth trajectory in the quarters ahead.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations